| Target | |
|---|---|
| Description | Monoclonal Cell Line Derived from Jurkat Cells, Engineered for Stable Expression of Human VSIG4 Using Lentiviral Technology |
| Host Cells | Jurkat |
| Uniprot ID | Q9Y279 |
| Applications | FACS Data |
| Growth media | RPMI-1640+10% FBS+1% P.S+1% Gln+2 ug/mL Puromycin |
| Package | 5E6 Cells/mL |
| Host Species | Human |
| Suggested Control | SKU: DMC100268 |
| Warranty and Disclaimer | 1. Please inspect cells upon receipt and report any issues promptly. 2. We offer one-time replacements for issues reported within a week of receipt. 3. User-induced issues are not eligible for free replacements. 4. We do not accept liability for damages resulting from cell use, storage, or loss. 5. Feedback received more than one month after receipt will not be processed. |
| Storage & Shipping | Cells are shipped using dry ice and require liquid nitrogen storage for long term preservation. |
| Synonyms | CRIg; Z39IG |
| Background | This gene encodes a v-set and immunoglobulin-domain containing protein that is structurally related to the B7 family of immune regulatory proteins. The encoded protein may be a negative regulator of T-cell responses. This protein is also a receptor for the complement component 3 fragments C3b and iC3b. Alternate splicing results in multiple transcript variants. |
| Usage | For research use only. |
Hu_VSIG4 Jurkat Cell Line
Price:Inquiry
Product Data
Images
Figure 1. Flow cytometry analysis of human VSIG4 overexpression using Hu_VSIG4 Jurkat Cell Line (Cat. No. CEL100087) and Anti-VSIG4 antibody(DMC268)IgG1 Chimeric mAb (Cat. No. DMC100268)